MOTS (Motus GI Holdings) Days Inventory : 1,798.39 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Motus GI Holdings's Average Total Inventories for the three months ended in Mar. 2024 was $0.24 Mil. Motus GI Holdings's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.01 Mil. Hence, Motus GI Holdings's Days Inventory for the three months ended in Mar. 2024 was 1,798.39.

The historical rank and industry rank for Motus GI Holdings's Days Inventory or its related term are showing as below:

MOTS's Days Inventory is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 184.43
* Ranked among companies with meaningful Days Inventory only.

Motus GI Holdings's Days Inventory increased from Mar. 2023 (249.63) to Mar. 2024 (1,798.39). It might indicate that Motus GI Holdings's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Motus GI Holdings's Inventory Turnover for the three months ended in Mar. 2024 was 0.05.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Motus GI Holdings's Inventory-to-Revenue for the three months ended in Mar. 2024 was 3.70.

Motus GI Holdings Days Inventory Historical Data

The historical data trend for Motus GI Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings Days Inventory Chart

Motus GI Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

1,391.56

669.29

380.50

225.60

235.10

Motus GI Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Inventory	Get a 7-Day Free Trial															249.63	680.64	810.79	104.01	1,798.39

Competitive Comparison of Motus GI Holdings's Days Inventory

For the Medical Devices subindustry, Motus GI Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's Days Inventory falls into.

Save Embed

;

Save Embed

;

Motus GI Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Motus GI Holdings's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.488	+	0.245)	/	2 )	/	0.569	*	365
=	0.3665					/	0.569	*	365
=	235.10

Motus GI Holdings's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

	Days Inventory (Q: Mar. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.245	+	0.228)	/	2 )	/	0.012	*	365 / 4
=	0.2365					/	0.012	*	365 / 4
=	1,798.39

Motus GI Holdings (OTCPK:MOTS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Motus GI Holdings's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.012	/	0.2365
	=	0.05

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Motus GI Holdings's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.2365	/	0.064
	=	3.70

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Motus GI Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Motus GI Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs, and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Executives

Orchestra Biomed Holdings, Inc.	10 percent owner	150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin	director	PO BOX 376, ANN ARBOR MI 48106
Elad Amor	officer: Chief Accounting Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram	officer: Chief Financial Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran	director, officer: Chief Executive Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor	officer: Chief Financial Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz	director, officer: President and COO	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp	other: * See Remarks	200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg	other: * See Remarks	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman	director, other: Chairman of the Board	15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy	director	850 PARK AVENUE, APT. 12B, NEW YORK NY 10075